Prognostic factors for patients with spinal metastases from lung cancer

Spine

Volumn 31, Issue 14, 2006, Pages 1585-1590

  Ogihara, Satoshi ^a   Seichi, Atsushi ^b   Hozumi, Takahiro ^a   Oka, Hiroyuki ^a   Ieki, Ryuuji ^a   Nakamura, Kozo ^b   Kondoh, Taiji ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Indication for operation; Lung cancer; Prognostic factor; Spinal metastasis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; HAZARD ASSESSMENT; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERFORMANCE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SPINAL CORD METASTASIS; SPINE SURGERY; SURVIVAL TIME; TREATMENT INDICATION; UNIVARIATE ANALYSIS;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CALCIUM; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SPINAL CORD DISEASES; SPINAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33745233105     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000222146.91398.c9     Document Type: Article

References (16)

1. Shibuya K, Mathers CD, Boschi-Pinto C, et al. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002;2:37.
2. Johnston AD. Pathology of metastatic tumors in bone. Clin Orthop 1970;73:8-32.
3. Napoli LD, Hansen HH, Muggia FM, et al. The incidence of osseous involvement in lung cancer, with changes. Radiology 1973;108:17-21.
4. Tokuhashi Y, Matsuzaki H, Toriyama S, et al. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine 1990;15:1110-3.
5. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine 2001;26:298-306.
6. Pass HL, Pass HI. Lung Cancer: Principles and Practice. Philadelphia: Lippincott Williams & Wilkins, 2004.
7. Cox DR. Regression models and life tables. JR Stat Soc B 1972;34:187-220.
8. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
9. Takai E, Yano T, Iguchi H, et al. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma. Cancer 1996;78:1384-7.
10. Seichi A, Kondoh T, Hozumi T, et al. Intraoperative radiation therapy for metastatic spinal tumors. Spine 1999;24:470-5.
11. Frankel HL. Ascending cord lesion in the early stages following spinal injury. Paraplegia 1969;7:111-8.
12. Brundage MD, Davies D, Mackillop WJ, et al. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-57.
13. Rawson NS, Petro J. An overview of prognostic factors in small cell lung cancer: a report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. Br J Cancer 1990;61:597-604.
14. Desmond Y, Peter GH. Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer 2000;28:173-85.
15. Enkaoua EA, Doursounian L, Chatellier G, et al. Vertebral metastases, a critical application of the preoperative prognostic Tokuhashi score in a series of 71 cases. Spine 1997;22:2293-8.
16. Hirabayashi H, Ebara S, Kinoshita T, et al. Clinical outcome and survival after palliative surgery for spinal metastases: palliative surgery in spinal metastases. Cancer 2003;97:476-84.